• Skip to primary navigation
  • Skip to main content

Research Initiatives and Infrastructure

University of Southern CaliforniaResearch and Innovation
  • Funding
  • Limited Submissions
  • Shared Resources
  • Training
  • Announcements
  • Contact
You are here: Home / Limited Submissions / (CLOSED) Takeda/New York Academy of Sciences Innovators in Science Award: Cancer Immunology

(CLOSED) Takeda/New York Academy of Sciences Innovators in Science Award: Cancer Immunology

Slots: Both Early-Career Scientist and Senior Scientist slots taken.

Deadlines

Internal Deadline: Closed.

Nomination Deadline: Friday, March 31, 2023, 11:59pm ET

Letter of Support Deadline: Friday, April 14, 2023, 11:59pm ET (Letters of Support Due)

Award Information

Award Type: Grant

Anticipated Award Amount: $200,000

Who May Serve as PI: 

Early-Career Scientist

The nominee must:

  • Have been engaged in active research for a length of time of 10 years or less since gaining their doctorate degree or equivalent.
  • Hold a doctorate degree (PhD, DPhil, MD, DDS, DVM, etc.).
  • Currently hold a junior level Post-doctoral or Faculty position at an invited academic, government, or non-profit institution or equivalent.
  • Have made impactful research contributions and show exceptional promise for significant future achievement in the Award field.

In the event that an Early-Career Scientist nominee has taken a maternity, paternity, adoptive, family care, military, or extended sick leave (in line with their current institution’s policies) during the 10 years since gaining their doctoral degree or equivalent, they can qualify for an extension of the eligibility timeframe. Instructions regarding how to request an extension are provided at the end of the Guidelines section.

Senior Scientist

The nominee must:

  • Have been engaged in active research for a length of time of more than 10 years since gaining their doctorate degree or equivalent.
  • Hold a doctorate degree (PhD, DPhil, MD, DDS, DVM, etc.).
  • Currently hold a senior level Faculty position at an invited academic, government, or non-profit institution or equivalent.
  • Have made multiple, extensive, and impactful research contributions to advance the Award field.

Link to Award: https://www.nyas.org/awards/innovators-in-science-award/

Process for Limited Submissions

PIs must submit their application as a Limited Submission through the Research Initiatives and Infrastructure (RII) Application Portal: https://rii.usc.edu/oor-portal/. Use the template provided here:

RII-Limited-Submission-Application-Template.Download

Materials to submit include:

  • (1) Two-Page Proposal Summary (0.5” margins; single-spaced; font type: Arial, Helvetica, or Georgia typeface; font size: 11 pt). Page limit includes references and illustrations. Pages that exceed the 2-page limit will be excluded from review. You must use the template linked above.
  • (2) CV – (5 pages maximum)

Note: The portal requires information about the PIs in addition to department and contact information, including the 10-digit USC ID#, Gender, and Ethnicity. Please have this material prepared before beginning this application.

Purpose

Established in 2016, the Innovators in Science Award is administered by the New York Academy of Sciences and sponsored by Takeda. This global award recognizes a promising Early-Career Scientist’s and an outstanding Senior Scientist’s contributions to biomedical science and is intended to support their commitment to innovative research. Select international institutions are invited to submit nominations. Each winner receives an unrestricted prize of US$200,000 for their excellence in, and commitment to, innovative science that has significantly advanced a rotating focus area. 

The 2024 Innovators in Science Award will recognize achievements in Cancer Immunology. Cancer remains the second-leading cause of death worldwide, and the global burden is expected to rise as the population grows and ages.1 Despite major advances in the drug development pipeline, about only 11% of new cancer therapeutics make it into the clinic.2 This Award recognizes bold, creative scientists seeking to increase our molecular and immunological understanding of cancer and inform novel therapeutic approaches.

Review Criteria:

Early-Career Scientist

  • Quality: The extent to which the work is reliable, valid, credible, and scientifically rigorous.
  • Impact: The extent to which the work represents a significant contribution in basic, translational, or clinical research that has impacted, or has strong potential to impact, human health through the diagnosis, treatment, or prevention of disease.
  • Novelty: The extent to which the work challenges existing paradigms, employs innovative new methodologies or concepts, and/or pursues an original question.
  • Promise: The extent to which the nominee has made innovative research contributions and shows exceptional promise for significant future achievement in the Award field.

Senior Scientist

  • Quality: The extent to which the work is reliable, valid, credible, and scientifically rigorous.
  • Impact: The extent to which the work represents a significant contribution in basic, translational, or clinical research that has impacted, or has strong potential to impact, human health through the diagnosis, treatment, or prevention of disease.
  • Novelty: The extent to which the work challenges existing paradigms, employs new innovative methodologies or concepts, and/or pursues an original question.
  • Promise: The extent to which the nominee has made impactful research contributions and future prospects for further significant contributions in the Award field.

Visit our Institutionally Limited Submission webpage for more updates and other announcements.

Research Initiatives and Infrastructure
Third Floor, 3720 Flower St, Los Angeles, CA 90007
rii@usc.edu

University of Southern California   Content managed by RII
  • Privacy Notice - Notice of Non-Discrimination